The GLOW Study - The YANG System

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

June 19, 2021

Study Completion Date

June 19, 2021

Conditions
Diabetes MellitusGlucose
Interventions
DEVICE

The YANG SENSOR is an active implantable device, for Real Time Continuous Glucose, Lactate and Ketone Measurement

The YANG SENSOR is an active implantable device, that is intended to be implanted in the subcutaneous abdominal tissue, approximately 10mm below the skin. The SENSOR is battery powered. The battery is wirelessly recharged through the skin by the YANGEXD, using a charging coil ('Donut') applied to the skin with an adhesive patch at the level of the SENSOR. The 'Donut' also receives data from the sensor.

Trial Locations (1)

2650

University Hospital Antwerp, Edegem

All Listed Sponsors
collaborator

University Hospital, Antwerp

OTHER

lead

Indigo Diabetes NV

INDUSTRY

NCT04782934 - The GLOW Study - The YANG System | Biotech Hunter | Biotech Hunter